Company Filing History:
1 out of 1,290 
1 out of 109 
1 out of 3,107 
Years Active: 2015
Title: Chie Aoki: Innovator in Hepatitis C Research
Introduction
Chie Aoki is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of virology, particularly in the study of the hepatitis C virus (HCV). His innovative work has led to advancements in understanding and potentially treating this infectious disease.
Latest Patents
Chie Aoki holds a patent for an invention titled "Infectious hepatitis C virus—high producing HCV variants and use thereof." The objective of this invention is to provide an HCV strain with a high capacity for virus production in a cell culture system. This invention includes a nucleic acid encoding a polyprotein precursor of the hepatitis C virus JFH1 strain, which features one or more amino acid substitutions. Notably, the polyprotein precursor comprises at least a substitution of glutamine at position 862 with arginine, as determined with reference to the amino acid sequence shown in SEQ ID NO: 2 in the Sequence Listing. He has 1 patent to his name.
Career Highlights
Throughout his career, Chie Aoki has worked with prestigious institutions, including the University of Tokyo and Nihon University. His research has focused on developing methods to enhance the production of HCV variants, which is crucial for vaccine development and therapeutic research.
Collaborations
Chie Aoki has collaborated with notable colleagues in his field, including Yoshihiro Kitamura and Yoko Shimizu. Their combined expertise has contributed to the advancement of research in hepatitis C and related viral studies.
Conclusion
Chie Aoki's innovative work in hepatitis C research exemplifies the importance of scientific inquiry in addressing global health challenges. His contributions continue to pave the way for future advancements in virology and therapeutic development.